ProfileGDS4718 / 204026_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 92% 69% 96% 93% 98% 97% 95% 91% 97% 95% 93% 97% 98% 97% 97% 94% 98% 97% 98% 96% 95% 95% 96% 98% 97% 92% 96% 96% 98% 98% 98% 89% 92% 90% 97% 98% 92% 94% 70% 95% 98% 90% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.273597
GSM549102patient 115, normal, homogenized [OPG study]9.6369592
GSM549104patient 119, normal, homogenized [OPG study]6.8273669
GSM549108patient 138, normal, homogenized [OPG study]10.580796
GSM549119patient 077, normal, homogenized [OPG study]9.8070793
GSM549133patient 032, cancer, homogenized [OPG study]11.482998
GSM549139patient 042, cancer, homogenized [OPG study]10.950197
GSM549099patient 107, normal, homogenized [OPG study]10.310895
GSM549109patient 139, normal, homogenized [OPG study]9.3388691
GSM549110patient 046, normal, homogenized [OPG study]11.033397
GSM549114patient 063, normal, homogenized [OPG study]10.349295
GSM549122patient 082, normal, homogenized [OPG study]9.6947193
GSM549134patient 033, cancer, homogenized [OPG study]11.088397
GSM549136patient 036, cancer, homogenized [OPG study]11.437298
GSM549140patient 044, cancer, homogenized [OPG study]10.834197
GSM549111patient 047, normal, homogenized [OPG study]11.084997
GSM549113patient 057, normal, homogenized [OPG study]10.254294
GSM549132patient 031, cancer, homogenized [OPG study]11.163598
GSM549137patient 038, cancer, homogenized [OPG study]10.784397
GSM549142patient 047, cancer, homogenized [OPG study]10.669298
GSM549100patient 110, normal, homogenized [OPG study]10.608896
GSM549107patient 135, normal, homogenized [OPG study]10.401495
GSM549115patient 068, normal, homogenized [OPG study]10.619895
GSM549116patient 072, normal, homogenized [OPG study]10.773496
GSM549120patient 078, normal, homogenized [OPG study]11.46598
GSM549131patient 030, cancer, homogenized [OPG study]10.872797
GSM549118patient 074, normal, homogenized [OPG study]9.6057592
GSM549129patient 027, cancer, homogenized [OPG study]10.377796
GSM549123patient 088, normal, homogenized [OPG study]10.52496
GSM549124patient 006, cancer, homogenized [OPG study]11.104898
GSM549126patient 015, cancer, homogenized [OPG study]11.121598
GSM549128patient 025, cancer, homogenized [OPG study]11.153798
GSM549103patient 117, normal, homogenized [OPG study]8.9490989
GSM549117patient 073, normal, homogenized [OPG study]9.72192
GSM549138patient 041, cancer, homogenized [OPG study]9.1976990
GSM549141patient 045, cancer, homogenized [OPG study]10.937597
GSM549130patient 028, cancer, homogenized [OPG study]11.328298
GSM549101patient 111, normal, homogenized [OPG study]9.5904192
GSM549105patient 128, normal, homogenized [OPG study]10.049194
GSM549106patient 134, normal, homogenized [OPG study]6.9257970
GSM549112patient 048, normal, homogenized [OPG study]10.43295
GSM549125patient 011, cancer, homogenized [OPG study]11.206998
GSM549127patient 024, cancer, homogenized [OPG study]9.1524490
GSM549135patient 035, cancer, homogenized [OPG study]10.939697